Skip to main content

Table 2 Comparison of clinical features of patients in the restenosis and non-restenosis groups

From: Diagnostic value of microRNA-143 in predicting in-stent restenosis for patients with lower extremity arterial occlusive disease

Feature

Restenosis group (n = 74)

Non-restenosis group (n = 91)

P

Age (years)

65.4 ± 8.6

64.7 ± 8.0

0.583

Male, n (%)

52 (70.2)

60 (65.9)

0.553

BMI (kg/m2)

24.8 ± 3.6

24.1 ± 3.2

0.184

Hypertension, n (%)

19 (25.7)

22 (24.2)

0.825

Hyperlipidemia, n (%)

15 (20.3)

17 (18.7)

0.797

Renal dysfunction, n (%)

10 (13.5)

11 (12.1)

0.785

Diabetes, n (%)

21 (28.4)

6 (6.6)

<0.001

Smoking, n (%)

59 (79.7)

27 (29.7)

<0.001

Drinking, n (%)

33 (44.6)

40 (44.0)

0.935

SBP (mmHg)

137.8 ± 22.3

133.6 ± 21.5

0.221

DBP (mmHg)

73.4 ± 9.8

72.6 ± 7.7

0.558

HDL-C (mmol/L)

1.1 ± 0.3

1.2 ± 0.3

0.177

LDL-C (mmol/L)

3.0 ± 0.5

2.5 ± 0.3

<0.001

Blood sugar, (mmol/L)

6.3 ± 2.0

5.4 ± 1.8

<0.001

Stent mean diameter (mm)

7.4 ± 1.0

6.6 ± 1.0

<0.001

  1. BMI body mass index; SBP systolic blood pressure; DBP diastolic blood pressure; HDL-C high-density lipoprotein cholesterol; LDL-C low-density lipoprotein cholesterol